A promising weight loss alternative to bariatric surgery

GLP-1-based polyagonists have shown significant success in the treatment of obesity, leading to body fat reductions of 20-30% in some cases. The drugs, originally developed for type 2 diabetes, also reduce blood glucose levels and kidney disease, as well as improve cardiovascular function. They are being seen as a potential alternative to bariatric surgery in treating obesity.